Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navigator vs Standard Needle for Hip Injection
NCT02066844Phase 2Completed
- Sponsor
- Cartiva, Inc.
- Start
- Feb 2014
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by Cartiva, Inc. Primary endpoint: Injection Pain at 12 weeks. Started Feb 2014; status: completed.
Beyond the preview
Go deeper on NCT02066844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066844.